 |
|
A Common NURR1 Polymorphism Associated With Parkinson Disease and Diffuse Lewy Body Disease
Kangni Zheng, MD;
Bobak Heydari, BS;
David K. Simon, MD, PhD
Arch Neurol. 2003;60:722-725.
Background NURR1 plays a key role in mesencephalic dopaminergic neuron development and survival. A homozygous NURR1 polymorphism (a single base-pair insertion in intron 6) (NI6P) has been reported to be associated with Parkinson disease (PD).
Objective To assess the association of the NI6P with PD and diffuse Lewy body disease.
Design Case-control study.
Setting Movement disorders clinic and tissue provided by brain banks.
Patients Patients with pathologically proven PD (n = 37) or diffuse Lewy body disease (n = 35), neuropathologically normal control subjects (n = 59), those clinically diagnosed as having PD (n = 66), and spousal controls (n = 29).
Methods Determining the frequency of heterozygotes and homozygotes for the NI6P by DNA sequencing and restriction endonuclease analyses.
Results Overall, 41 (39.8%) of the 103 patients with PD were heterozygotes compared with 22 (25.0%) of the 88 controls (P = .03), with a relative risk (estimated from the odds ratio) for PD of 2.03 (95% confidence interval, 1.08-3.81) for heterozygotes vs wild type subjects. Heterozygotes were more frequent in the subgroup of patients with pathologically confirmed PD (18 [48.6%] of 37) vs controls (14 [23.7%] of 59) (P = .01), with a relative risk for PD of 2.84 (95% confidence interval, 1.17-6.88) for heterozygotes vs wild type subjects. In patients clinically diagnosed as having PD, heterozygotes were more frequent in early-onset cases (onset at  45 years) (10 [55.6%] of 18) compared with late-onset cases (onset at >45 years) (10 [23.8%] of 42) (P = .02) or spousal controls (8 [27.6%] of 29) (P = .06), with a relative risk for early-onset PD of 4.17 (95% confidence interval, 1.13-15.33) for heterozygotes vs subjects with 2 wild type alleles. The homozygous NI6P was not associated with PD, but was present in 6 (17.1%) of the 35 patients with diffuse Lewy body disease compared with 3 (5.1%) of the 59 controls (P = .06).
Conclusions The common heterozygous NI6P is associated with an increased risk of PD. An association of borderline significance was found for the homozygous NI6P and diffuse Lewy body disease.
From the Department of Neurology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Mass.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Merging Mouse Transcriptome Analyses with Parkinson's Disease Linkage Studies
Gherbassi et al.
DNA Res 2007;0:dsm007v1-11.
ABSTRACT
| FULL TEXT
Absence of NR4A2 exon 1 mutations in 108 families with autosomal dominant Parkinson disease
Ibanez et al.
Neurology 2004;62:2133-2134.
FULL TEXT
Extended mutation analysis and association studies of Nurr1 (NR4A2) in Parkinson disease
Hering et al.
Neurology 2004;62:1231-1232.
FULL TEXT
Genome-wide linkage analysis and evidence of gene-by-gene interactions in a sample of 362 multiplex Parkinson disease families
Pankratz et al.
Hum Mol Genet 2003;12:2599-2608.
ABSTRACT
| FULL TEXT
|
